China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals, Inc. (SXTC) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for China SXT Pharmaceuticals, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
- Sector
- Healthcare
- Industry
- Drug manufacturers specialty generic
- Country
- China
- Exchange
- Nasdaq
- CEO
- Feng Zhou
- Employees
- 75
- IPO date
- 04 Jan 2019
- ISIN
- VGG2161P1650
- Website
- sxtchina.com
Frequently asked questions
Where is China SXT Pharmaceuticals, Inc. stock listed?
China SXT Pharmaceuticals, Inc. (SXTC) is listed on Nasdaq.